Compare TBPH & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBPH | CTBI |
|---|---|---|
| Founded | 2013 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 993.7M | 959.5M |
| IPO Year | N/A | N/A |
| Metric | TBPH | CTBI |
|---|---|---|
| Price | $18.73 | $57.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $27.80 | ★ $59.00 |
| AVG Volume (30 Days) | ★ 601.0K | 48.2K |
| Earning Date | 11-10-2025 | 01-14-2026 |
| Dividend Yield | N/A | ★ 3.69% |
| EPS Growth | N/A | ★ 17.49 |
| EPS | 0.58 | ★ 5.17 |
| Revenue | $80,327,000.00 | ★ $261,447,000.00 |
| Revenue This Year | $70.78 | $21.01 |
| Revenue Next Year | N/A | $6.33 |
| P/E Ratio | $32.19 | ★ $11.12 |
| Revenue Growth | ★ 27.12 | 13.97 |
| 52 Week Low | $7.90 | $44.60 |
| 52 Week High | $20.33 | $59.83 |
| Indicator | TBPH | CTBI |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 64.65 |
| Support Level | $18.39 | $54.83 |
| Resistance Level | $20.32 | $56.41 |
| Average True Range (ATR) | 0.87 | 1.11 |
| MACD | -0.05 | 0.34 |
| Stochastic Oscillator | 53.71 | 90.10 |
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.